In the context of hepatic metabolism, Sirt2 emerges as a protector against fatty liver disease and hepatic steatosis by stabilizing HNF4α via deacetylation [10], thus promoting the expression of genes involved in lipid, amino acid, and glucose metabolism, and influencing inflammatory networks [11]. This evidence concerns the gene HNF4A and fatty liver disease.